| Die Webseite der GALANTOS GENETICS GMBH Vaterschaftstest, DNA, Gentest, Abstammungstest, finden Sie unter www.galantos.de |
 GALANTOS
GENETICS GMBH |
| Die Webseite der GALANTOS GENETICS GMBH Vaterschaftstest, DNA, Gentest, Abstammungstest, finden Sie unter www.galantos.de |
GALANTOS
GENETICS GMBH |
|
Business Development
Galantos Pharma GmbH wants to finalize the preclinical development, Phase I and PoC in man of its clinical candidate. We anticipate a CTA / IND in Q3 2011. The company currently pursues the following options for clinical development / partnering: 1) Secure a financing round of 5 M€ to complete the clinical development until Phase Ib to obtain proof-of-concept (PoC) in man and outlicense. 2) Secure a financing round of 15-20 M€ for complete clinical development until Phase II to obtain PoC in patients and outlicense. 3) Deveop neuroprotective compounds (nicotinic alpha 7 modulators) with support from the German Ministry of Education and Research (BMBF) and collaborate with partner(s) from the pharmaceutical industry. 4) Identify partners to develop lead products in other neurodegenerative diseases, like Parkinson's, Huntington's, schizophrenia or depression that show cognitive abnormalities.
|
